-
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.
Cell. 1986 Jan 31;44(2):283-92
PMID: 3943125
-
Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates.
Vaccine. 1998 May;16(8):842-9
PMID: 9627942
-
Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.
J Virol. 1988 May;62(5):1530-4
PMID: 2833606
-
Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus.
J Gen Virol. 1988 Aug;69 ( Pt 8):2101-7
PMID: 3404125
-
Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.
J Immunol. 1988 Nov 15;141(10):3606-10
PMID: 2460542
-
Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells.
Virology. 1989 Apr;169(2):354-64
PMID: 2523178
-
Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.
J Gen Virol. 1989 Aug;70 ( Pt 8):2037-49
PMID: 2549181
-
Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.
Am J Trop Med Hyg. 1989 Nov;41(5):576-80
PMID: 2817214
-
Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
Virology. 1991 Jan;180(1):294-305
PMID: 1845826
-
Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein.
Lancet. 1991 Mar 9;337(8741):567-72
PMID: 1671940
-
Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus.
Virology. 1991 Nov;185(1):401-10
PMID: 1833876
-
Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.
Virology. 1992 Mar;187(1):290-7
PMID: 1736531
-
Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection.
Virology. 1992 Jun;188(2):714-20
PMID: 1585642
-
A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine.
Virology. 1992 Sep;190(1):454-8
PMID: 1326813
-
Heterologous protection against influenza by injection of DNA encoding a viral protein.
Science. 1993 Mar 19;259(5102):1745-9
PMID: 8456302
-
Gene inoculation generates immune responses against human immunodeficiency virus type 1.
Proc Natl Acad Sci U S A. 1993 May 1;90(9):4156-60
PMID: 8483929
-
Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.
Vaccine. 1993;11(9):957-60
PMID: 8212843
-
Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
Virology. 1994 Feb 15;199(1):132-40
PMID: 8116236
-
Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice.
Vaccine. 1994;12(3):279-85
PMID: 8165861
-
Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens.
Vaccine. 1994 May;12(7):633-8
PMID: 8085382
-
Immunization with DNA.
J Immunol Methods. 1994 Dec 2;176(2):145-52
PMID: 7983375
-
Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.
J Immunol. 1995 Feb 1;154(3):1287-95
PMID: 7529799
-
Sindbis vectors suppress secretion of subviral particles of Japanese encephalitis virus from mammalian cells infected with SIN-JEV recombinants.
Virology. 1995 May 10;209(1):155-66
PMID: 7747465
-
Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form.
J Virol. 1995 Sep;69(9):5816-20
PMID: 7637027
-
Flavivirus-cross-reactive, HLA-DR15-restricted epitope on NS3 recognized by human CD4+ CD8- cytotoxic T lymphocyte clones.
J Gen Virol. 1995 Sep;76 ( Pt 9):2243-9
PMID: 7561761
-
Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones.
J Virol. 1996 Jan;70(1):141-7
PMID: 8523518
-
Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells.
J Gen Virol. 1996 Apr;77 ( Pt 4):705-14
PMID: 8627259
-
Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus.
Arch Virol. 1996;141(3-4):743-9
PMID: 8645110
-
Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses.
Curr Opin Immunol. 1996 Aug;8(4):472-7
PMID: 8794015
-
Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
Virology. 1997 Jan 20;227(2):353-60
PMID: 9018134
-
DNA vaccines -- a modern gimmick or a boon to vaccinology?
Crit Rev Immunol. 1997;17(2):139-54
PMID: 9094450
-
Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice.
Vaccine. 1997 Apr;15(5):547-52
PMID: 9160523
-
Recombinant viruses as vaccines and immunological tools.
Curr Opin Immunol. 1997 Aug;9(4):517-24
PMID: 9287173
-
Partial nucleotide sequence of the Japanese encephalitis virus genome.
Virology. 1987 Jun;158(2):348-60
PMID: 3035787